An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions
Recurrent Ovarian Cancer
Trial Locations (2)

27356

Diakoniekrankenhaus, Gynäkologie und Geburtshilfe, Rotenburg (Wümme)

85567

Praxis und Tagesklinik für gynäkologische Onkologie, Ebersberg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PharmaMar, Spain

INDUSTRY

NCT01869400 - An Observational Study of YONDELIS®+PLD for the Treatment of Patients With Platinum-sensitive Relapse of Ovarian Cancer | Biotech Hunter | Biotech Hunter